[CBM] Cambrex Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 1.85 B

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 54.15 Change: 1.45 (2.75%)
Ext. hours: Change: 0 (0%)

chart CBM

Refresh chart

Strongest Trends Summary For CBM

CBM is in the long-term up 1220% in 15 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products consist of active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products. The company serves generic drug companies, and companies that discover and commercialize new small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

Fundamental Ratios
Shares Outstanding31.98 M EPS2.85 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -20.81% Sales Growth - Q/Q-40.05% P/E20.14
P/E To EPS Growth P/S4.8 P/BV7.6 Price/Cash Per Share
Price/Free Cash Flow44.54 ROA13.37% ROE26.34% ROI17.57%
Current Ratio2.2 Quick Ratio1.18 Long Term Debt/Equity0.47 Debt Ratio0.43
Gross Margin35.31% Operating Margin16.19% Net Profit Margin16.66% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.6 M Cash From Investing Activities-12.04 M Cash From Operating Activities35.37 M Gross Profit29.08 M
Net Profit7.99 M Operating Profit12.67 M Total Assets481.08 M Total Current Assets233.17 M
Total Current Liabilities106.17 M Total Debt60 M Total Liabilities236.88 M Total Revenue77.53 M
Technical Data
High 52 week68.4 Low 52 week35.8 Last close60 Last change-0.25%
RSI78.12 Average true range2.66 Beta1.21 Volume174.76 K
Simple moving average 20 days29.7% Simple moving average 50 days33.45% Simple moving average 200 days36.74%
Performance Data
Performance Week44.89% Performance Month30.8% Performance Quart32.95% Performance Half52.21%
Performance Year7.72% Performance Year-to-date58.9% Volatility daily8.53% Volatility weekly19.08%
Volatility monthly39.11% Volatility yearly135.47% Relative Volume145.8% Average Volume405.21 K
New High New Low

News

2019-10-10 09:30:01 | ALXN vs. CBM: Which Stock Should Value Investors Buy Now?

2019-09-26 16:45:00 | INVESTOR ALERT: Monteverde & Associates PC Continues to Investigate the Following Transactions

2019-09-25 17:17:30 | Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Highlands, Cambrex, Two River, and Carbon Black on behalf of Stockholders and Encourages Investors to Contact the Firm

2019-09-23 13:28:37 | Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – NCI, CBM, VSI, WAIR

2019-09-23 06:40:00 | Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement

2019-09-20 17:00:00 | CBM, SEMG, ALDR: Monteverde & Associates PC Reminds Investors of an Ongoing Inquiry Regarding the Acquisition

2019-09-17 17:33:00 | Lifshitz & Miller LLP Announces Investigation of Avedro, Inc., Cambrex Corporation, Cardinal Health, Inc., Farfetch Limited Investors, Gannett Co., Inc., Pluralsight, Inc., Textron, Inc. and Vitamin Shoppe, Inc.

2019-09-17 10:44:46 | Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – CBM, WAIR, AVDR, PSDO

2019-09-13 09:40:01 | ALXN or CBM: Which Is the Better Value Stock Right Now?

2019-09-11 20:15:50 | Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Cambrex, Presidio, Old Line Bancorp, and Milacron Holdings on behalf of Stockholders and Encourages Investors to Contact the Firm

2019-09-11 13:18:45 | Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – CBM, WAIR, SRCI, MCRN

2019-09-10 13:50:00 | URGENT: Monteverde & Associates PC Reminds Investors of its Pending Investigation Regarding the Merger

2019-09-10 10:39:35 | MAMS, CBM, ABDC, and NCI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

2019-09-09 12:00:00 | SHAREHOLDER ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - CBM, WAIR, UCFC

2019-09-06 17:50:41 | SHAREHOLDER ALERT: WeissLaw LLP Reminds NRCG, NCI, CBM, and TRCB Shareholders About Its Ongoing Investigations

2019-09-04 12:45:00 | SHAREHOLDER ALERT: HALPER SADEH LLP CONTINUES TO INVESTIGATE WHETHER THE SALE OF THESE COMPANIES IS FAIR TO SHAREHOLDERS - GCI, CBM, VSI

2019-09-04 09:39:37 | PVTL, CBM, VSI and AVDR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

2019-09-03 09:00:00 | Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – MCRN, TYPE, GHDX, CBM

2019-08-26 09:30:01 | ALXN vs. CBM: Which Stock Is the Better Value Option?

2019-08-19 12:38:34 | TRCB, VSI, CBM, and TRK SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

2019-08-16 16:25:24 | SHAREHOLDER ALERT: WeissLaw LLP Reminds CBM, VSI and NCI Shareholders About Its Ongoing Investigations

2019-08-16 11:45:00 | Shareholder Investigation Alert: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders - CBM, CVRS, VSI

2019-08-15 16:40:00 | URGENT: Monteverde & Associates PC Launches an Investigation Regarding the Following Buyout

2019-08-14 11:14:44 | Shareholder Investigation Alert: Halper Sadeh LLP is Investigating Whether The Sale of These Companies is Fair to Shareholders – CBM, GCI, WAIR, ACIA

2019-08-13 17:52:00 | CAMBREX INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cambrex Corporation - CBM

2019-08-13 12:32:45 | TRCB, AVDR, CBM, and NCI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

2019-08-13 11:01:06 | MERGER ALERT –NCI, AVDR, and CBM: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies

2019-08-12 21:05:00 | SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of Cambrex Corporation - CBM

2019-08-09 20:00:00 | URGENT: Monteverde & Associates PC is Investigating the Following Transaction

2019-08-09 11:17:32 | Shareholder Investigation Alert: Halper Sadeh LLP is Investigating Whether The Sale of These Companies is Fair to Shareholders – GCI, CBM, CVRS, VSI

2019-08-09 10:00:00 | GCI, CBM, VSI and CVRS SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

2019-08-09 09:30:01 | ALXN vs. CBM: Which Stock Should Value Investors Buy Now?

2019-08-08 16:54:00 | SHAREHOLDER ALERT: WeissLaw LLP Investigates Cambrex Corp.

2019-08-08 14:11:32 | Cambrex's Earnings Outlook

2019-08-08 10:29:21 | MERGER ALERT – NCI, GCI, and CBM: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies

2019-08-07 21:10:00 | SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Cambrex Corporation - CBM

2019-08-07 18:09:00 | Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Cambrex Corporation NYSE: CBM on Behalf of Cambrex Shareholders and Encourages Cambrex Investors to Contact the Firm

2019-08-07 16:02:48 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Cambrex Corporation to the Permira funds is Fair to Shareholders

2019-08-07 14:10:00 | ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cambrex Corporation

2019-08-07 12:55:00 | Cambrex Cancels Second Quarter Earnings Conference Call and Will Not Update Financial Guidance

2019-08-07 11:19:00 | Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Cambrex Corporation has obtained a Fair Price in its sale to Permira Funds

2019-08-07 10:15:00 | CAMBREX CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

2019-08-07 10:02:37 | Cambrex Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Cambrex Corporation is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – CBM

2019-08-07 09:13:27 | US STOCKS-Wall Street set to open lower as investors shun risk due to trade worries

2019-08-07 08:07:50 | Permira Funds To Acquire Cambrex In $2.4B Deal

2019-08-07 07:49:00 | Cambrex CBM Alert: Johnson Fistel Investigates Proposed Sale of Cambrex Corporation; Is $60 a Fair Price?

2019-08-07 07:42:40 | US STOCKS-Futures advance as Trump plays down trade worries

2019-08-07 07:05:05 | UPDATE 1-Permira Funds to buy drug contract manufacturer Cambrex for $2.02 bln

2019-08-07 06:46:00 | Cambrex stock rockets after $2.4 billion buyout deal at a 60% premium

2019-08-07 06:41:39 | Permira Funds to buy contract manufacturer Cambrex in $2.4 bln deal